摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(S)-N-{-oxo-3-[3-(4-trifluoromethoxy-phenyl)-1,4,5,6-tetrahydro-1,2-diaza-benzo[e]azulen-8-yl]-oxazolidin-5-ylmethyl}-acetamide | 741722-47-4

中文名称
——
中文别名
——
英文名称
(S)-N-{-oxo-3-[3-(4-trifluoromethoxy-phenyl)-1,4,5,6-tetrahydro-1,2-diaza-benzo[e]azulen-8-yl]-oxazolidin-5-ylmethyl}-acetamide
英文别名
(s)-n-{2-Oxo-3-[3-(4-trifluoromethoxy-phenyl)-1,4,5,6-tetrahydro-1,2-diaza-benzo[e]azulen-8-yl]-oxazolidin-5-ylmethyl}-acetamide;N-[[(5S)-2-oxo-3-[5-[4-(trifluoromethoxy)phenyl]-3,4-diazatricyclo[8.4.0.02,6]tetradeca-1(10),2(6),4,11,13-pentaen-12-yl]-1,3-oxazolidin-5-yl]methyl]acetamide
(S)-N-{-oxo-3-[3-(4-trifluoromethoxy-phenyl)-1,4,5,6-tetrahydro-1,2-diaza-benzo[e]azulen-8-yl]-oxazolidin-5-ylmethyl}-acetamide化学式
CAS
741722-47-4
化学式
C25H23F3N4O4
mdl
——
分子量
500.477
InChiKey
IFWQVVNYPAQHFJ-IBGZPJMESA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.5
  • 重原子数:
    36
  • 可旋转键数:
    5
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.32
  • 拓扑面积:
    96.6
  • 氢给体数:
    2
  • 氢受体数:
    8

反应信息

点击查看最新优质反应信息

文献信息

  • Selective androgen receptor modulators and methods for their identification, design and use
    申请人:Salvati E. Mark
    公开号:US20050256048A1
    公开(公告)日:2005-11-17
    Selective androgen receptor modulators (SARMs) having antagonist activity in hormone-dependent tumors while exhibiting no activity or agonist activity against other nontumor tissues containing the androgen receptor as well as methods for identifying, designing and using SARMs are provided.
    本发明提供了具有拮抗激素依赖性肿瘤活性的选择性雄激素受体调节剂(SARMs),同时对包含雄激素受体的其他非肿瘤组织没有活性或具有激动剂活性的方法,以及用于鉴定、设计和使用SARMs的方法。
  • ANTIBACTERIAL AGENTS
    申请人:Warner-Lambert Company LLC
    公开号:EP1594865A2
    公开(公告)日:2005-11-16
  • [EN] ANTIBACTERIAL AGENTS<br/>[FR] AGENTS ANTIBACTERIENS
    申请人:WARNER LAMBERT CO
    公开号:WO2004069832A2
    公开(公告)日:2004-08-19
    Compounds of formula (I) and methods for their preparation are disclosed. Further disclosed are methods of making biologically active compounds of formula I as well as pharmaceutically acceptable compositions comprising compounds of formula (I). Compounds of formula I as disclosed herein can be used in a variety of applications including use as antibacterial agents. Formula (I): wherein P is Formula (II), Formula (III), Formula (IV) or Formula (V).
查看更多